212-681-1575
Jul

31

Mesothelioma Drug Suffers Setback in Clinical Tria...

Posted by

Label: Featured News


Bayer, a global chemical, pharmaceutical and life sciences company, has announced that their investigational drug BAY 94-9343 (anetumab ravtansine) did not meet its primary endpoint in a phase II clinical trial. The company had hoped that the promising drug would

Read Full Story

Want Specific topic updates?


Once again research points to nature for help in fighting mesothelioma. MesotheliomaHelp has reported many times on the use of fruits, vegetables and other edible plants, including grapes, onions, and even sea cucumbers, in anti-cancer treatments. Now, researchers are looking

Read Full Story

Want Specific topic updates?


With immunotherapy being a new, and sometimes experimental, treatment for mesothelioma patients, the benefits are still being uncovered. However, so too are the side effects and drawbacks. This month’s news has brought updates on both the pros and cons of

Read Full Story

Want Specific topic updates?


With mesothelioma patients undergoing a similar treatment protocol to lung cancer patients, the mesothelioma community sits up and takes notice any time a new lung cancer drug receives approval from the  U.S. Food and Drug Administration. Last week, the FDA

Read Full Story

Want Specific topic updates?


A significant amount of research has focused on the role diet plays in the growth and spread of cancer. Some cancers, researchers believe, can be avoided if a healthy diet is adopted. Although mesothelioma is one cancer that can only

Read Full Story

Want Specific topic updates?

1 2 3 5